BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 6939934)

  • 1. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
    Isakov N; Feldman M; Segal S
    J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
    Isakov N; Feldman M; Segal S
    Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
    Gorelik E; Segal S; Feldman M
    J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the H-2.33 private specificity by 3LL tumor cells correlates with the tumor potential to metastasize across the H-2K region genetic barriers.
    Isakov N; Feldman M; Segal S
    Exp Clin Immunogenet; 1984; 1(3):170-4. PubMed ID: 6401004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells.
    Gorelik E; Fogel M; Feldman M; Segal S
    J Natl Cancer Inst; 1979 Dec; 63(6):1397-404. PubMed ID: 292811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities.
    Brodt P
    Cancer Res; 1986 May; 46(5):2442-8. PubMed ID: 3697987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic regulation of metastasis progression: the development of pulmonary metastases of the 3LL lung carcinoma is controlled by both a non-H-2 gene(s) and a gene(s) linked to the H-2D region of the mouse MHC.
    Isakov N; Feldman M; Segal S
    Transplant Proc; 1981 Mar; 13(1 Pt 2):778-82. PubMed ID: 7268896
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss of expression of transplantation antigens encoded by the H-2K locus on Lewis lung carcinoma cells and its relevance to the tumor's metastatic properties.
    Isakov N; Katzav S; Feldman M; Segal S
    J Natl Cancer Inst; 1983 Jul; 71(1):139-45. PubMed ID: 6345878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations.
    Gorelik E; Fogel M; Segal S; Feldman M
    J Supramol Struct; 1979; 12(3):385-402. PubMed ID: 94933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I major histocompatibility complex gene (H-2Ld).
    Itaya T; Yamagiwa S; Okada F; Oikawa T; Kuzumaki N; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1987 Jun; 47(12):3136-40. PubMed ID: 3107804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic cell therapy for a murine mammary carcinoma.
    Morecki S; Yacovlev E; Diab A; Slavin S
    Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of inoculation site on development of the Lewis lung carcinoma and suppressor cell activity in syngeneic mice.
    Malavé I; Blanca I; Fuji H
    J Natl Cancer Inst; 1979 Jan; 62(1):83-8. PubMed ID: 281579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma membrane microviscosity of Lewis lung carcinoma cells derived from local growth and pulmonary metastases.
    Rivnay B; Gorelik E; Segal S; Shinitzky M
    Invasion Metastasis; 1981; 1(2):99-110. PubMed ID: 7188384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of a human carcinoma (HEp3) in nude mice: rapid and efficient metastasis.
    Ossowski L; Russo H; Gartner M; Wilson EL
    J Cell Physiol; 1987 Nov; 133(2):288-96. PubMed ID: 3119604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor.
    Poggi A; Polentarutti N; Benedetta Donati M; de Gaetano G; Garattini S
    Cancer Res; 1977 Jan; 37(1):272-7. PubMed ID: 830414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in immunogenicity between the local tumor 3LL and its metastasis-derived line as detected by sensitization with antigen-fed macrophages.
    Brodt P; Segal S
    Invasion Metastasis; 1982; 2(3):185-96. PubMed ID: 7188394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting, accelerating and suppressing interactions between macrophages and tumor cells.
    De Baetselier P; Kapon A; Katzav S; Tzehoval E; Dekegel D; Segal S; Feldman M
    Invasion Metastasis; 1985; 5(2):106-24. PubMed ID: 3884534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.